StockData

Aibotics, Inc. (AIBT) stock

AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.00+0.00 (+42.86%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Aibotics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Aibotics's revenue for the twelve months ending Jun 30, 2026 was $0, down 100.0% year over year. For fiscal 2025 it was $2.18K.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.18K–
FY2024Dec 31, 2024$0–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0-100.0%
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$2.18K–
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2020Dec 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$3.56M–
Q2 FY2019Jun 30, 2019$3.91M–
Q3 FY2018Sep 30, 2018$3.35M–
Q2 FY2018Jun 30, 2018$3.41M–

More Aibotics figures

See a number that looks wrong?